Get the Stockscreener App
3.78
4.06%
-0.16
After Hours:
3.76
-0.02
-0.53%
Sonoma Pharmaceuticals Inc stock is traded at $3.78, with a volume of 17,472.
It is down -4.06% in the last 24 hours and down -5.26% over the past month.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$3.94
Open:
$3.97
24h Volume:
17,472
Relative Volume:
0.01
Market Cap:
$6.21M
Revenue:
$14.91M
Net Income/Loss:
$-3.56M
P/E Ratio:
-1.537
EPS:
-2.4593
Net Cash Flow:
$-1.37M
1W Performance:
-5.50%
1M Performance:
-5.26%
6M Performance:
+11.83%
1Y Performance:
+35.48%
1-Day Range:
$3.76
$3.97
1-Week Range:
$3.7286
$4.10
52-Week Range:
$1.75
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Name
Sonoma Pharmaceuticals Inc
Sector
Phone
800-759-9305
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
3.78 | 6.50M | 14.91M | -3.56M | -1.37M | -2.4593 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News
Sonoma Pharmaceuticals Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
How to interpret RSI for Sonoma Pharmaceuticals Inc. stockWeekly Stock Recap & Real-Time Volume Analysis - newser.com
What does recent volatility data suggest for Sonoma Pharmaceuticals Inc.Earnings Risk Summary & Reliable Trade Execution Plans - newser.com
Sentiment analysis tools applied to Sonoma Pharmaceuticals Inc.July 2025 Closing Moves & Technical Analysis for Trade Confirmation - newser.com
Intraday pattern recognizer results for Sonoma Pharmaceuticals Inc.Earnings Risk Report & High Return Stock Watch Alerts - newser.com
Predicting Sonoma Pharmaceuticals Inc. trend using moving averages2025 Price Momentum & Fast Gain Stock Trading Tips - newser.com
How analysts revise price targets for Sonoma Pharmaceuticals Inc. (O8Z) stockJuly 2025 Retail & Risk Controlled Stock Pick Alerts - newser.com
Is Sonoma Pharmaceuticals Inc. stock a dividend growth opportunityCEO Change & Long-Term Capital Growth Strategies - newser.com
Why Sonoma Pharmaceuticals Inc. stock is favored by top institutionsJuly 2025 Pullbacks & Safe Capital Growth Plans - newser.com
How Sonoma Pharmaceuticals Inc. stock benefits from tech adoptionEntry Point & Expert Curated Trade Setup Alerts - newser.com
Can Sonoma Pharmaceuticals Inc. (O8Z) stock sustain margin levels2025 Major Catalysts & Safe Capital Growth Plans - newser.com
How Sonoma Pharmaceuticals Inc. (O8Z) stock responds to job market shifts2025 Price Momentum & Community Driven Trade Alerts - newser.com
What downside risks could hit Sonoma Pharmaceuticals Inc. (O8Z) stockEarnings Growth Report & Pattern Based Trade Signal System - newser.com
Is Sonoma Pharmaceuticals Inc. stock a buy for dividend growthShort Setup & Long Hold Capital Preservation Plans - newser.com
Is Sonoma Pharmaceuticals Inc. stock gaining market shareJuly 2025 Levels & Weekly High Conviction Ideas - newser.com
Is Sonoma Pharmaceuticals Inc. stock in correction or buying zone2025 Analyst Calls & Weekly Watchlist of Top Performers - newser.com
Will Sonoma Pharmaceuticals Inc. (O8Z) stock rise with strong economyMarket Risk Summary & Proven Capital Preservation Methods - newser.com
Analyzing net buyer seller activity in Sonoma Pharmaceuticals Inc.Weekly Trend Summary & Daily Price Action Insights - newser.com
Will Sonoma Pharmaceuticals Inc. stock attract more institutional investorsTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com
Does Sonoma Pharmaceuticals Inc. stock trade at a discount to peersGold Moves & Real-Time Stock Entry Alerts - newser.com
Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.35%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):